Open AccessClinical efficacy of osimertinib for a patient with ileus due to peritoneal carcinomatosis
Author(s) -
Kawaguchi Yo,
Hanaoka Jun,
Hayashi Hideki,
Fukuda Yoshihisa,
Iihara Hirotoshi,
Suzuki Akio,
Sugiyama Tadashi
Publication year - 2020
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.2645
Subject(s) - medicine , peritoneal carcinomatosis , ileus , osimertinib , adenocarcinoma , carcinosis , lung , lung cancer , surgery , cancer , colorectal cancer , ros1
We report a patient of stage IV lung adenocarcinoma who developed ileus due to peritoneal carcinomatosis. We placed an ileus tube and started an oral intake of osimertinib. Within one month, the tumor had shrunk, and the ileus was controlled.